Literature DB >> 33838902

Biliary atresia liver histopathological determinants of early post-Kasai outcome.

Anh-Hoa Pham Nguyen1, Yen Hai T Pham1, Giap H Vu2, My Ha Nguyen1, Thach Ngoc Hoang1, AiXuan Holterman3.   

Abstract

BACKGROUND: A retrospective chart review of liver histologies in Kasai biliary atresia BA patients operated 1/2017- 7/2019 at our institution was conducted to identify histologic prognostic factors for biliary outcome.
METHODS: Patients with wedge liver biopsies and portal plate biopsies (n = 85) were categorized into unfavorable and favorable outcome, based on a 3-month serum total bilirubin level of <34 μM or mortality. Hepatocellular histologies, presence of ductal plate malformation (DPM) and of large bile duct of ≥ 150 μm diameter size at the portal plate were evaluated.
RESULTS: Total Bilirubin levels> 34 μM correlates with worse 1-year survival. Age at surgery, histologic fibrosis or inflammation does not predict outcome. Potential adverse predictors are severe hepatocellular swelling, severe cholestasis, presence of DPM (n = 24), and portal plate bile duct size < 150 µm (n = 28). In multivariate analyses adjusting for age at Kasai and postop cholangitis, bile duct size and severe hepatocellular swelling remain independent histologic prognosticators (OR 3.25, p = 0.039 and OR 3.26, p = 0.006 respectively), but not DPM.
CONCLUSION: Advanced histologic findings of portal plate bile duct size of <150 µm and severe hepatocellular damage predict poor post-Kasai jaundice clearance and short-term survival outcome, irrespective of Kasai timing. LEVEL OF EVIDENCE: Level III.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Bile duct size; Biliary atresia; Cholestasis; Ductal plate malformation; Kasai procedure; Prognostic factor

Year:  2021        PMID: 33838902     DOI: 10.1016/j.jpedsurg.2021.03.039

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

1.  IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients.

Authors:  Yuki Sengoku; Mayumi Higashi; Kazuya Nagayabu; Shohei Takayama; Shigehisa Fumino; Shigeyoshi Aoi; Taizo Furukawa; Tatsuro Tajiri
Journal:  Pediatr Surg Int       Date:  2022-09-23       Impact factor: 2.003

2.  Academic Pediatric Surgery Capacity Building in Vietnam Through PASS, a Pediatric Acute Surgical Support Course.

Authors:  Bich-Uyen Nguyen; Aixuan Holterman; Mark Holterman; Le-Thanh Dinh
Journal:  Front Surg       Date:  2022-04-20

3.  Analysis of Targeted Post-operative Nursing Outcome in 1246 Patients with Percutaneous Transhepatic Biliary Drainage.

Authors:  Xiuchun Yang; Yuelan Qin; Wei Mo; Hua Xiang; Zhichao Liu; Jianhua Long; Bin Xiang
Journal:  Front Surg       Date:  2022-04-27

Review 4.  Biliary Atresia Animal Models: Is the Needle in a Haystack?

Authors:  Nutan Pal; Parijat S Joy; Consolato M Sergi
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 5.  Peri-Operative Liver Fibrosis and Native Liver Survival in Pediatric Patients with Biliary Atresia: A Systematic Review and Meta-Analysis.

Authors:  Ashkan Jahangirnia; Irina Oltean; Youssef Nasr; Nayaar Islam; Arielle Weir; Joseph de Nanassy; Ahmed Nasr; Dina El Demellawy
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.